New CMO at IBT

Infant Bacterial Therapeutics is welcoming Erik Kinnman as Chief Medical Officer. Erik will contribute with his extensive knowledge and experience from the pharmaceutical industry to the on-going drug development program.
 
See Who we are here

August 22, 2014